Ensysce Biosciences (ENSCW) Other Non-Current Liabilities (2018 - 2025)

Ensysce Biosciences (ENSCW) has 8 years of Other Non-Current Liabilities data on file, last reported at $35.0 in Q3 2025.

• Other Non-Current Liabilities for Q3 2025 came in at $35.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was $35.0 (changed N/A YoY), and the FY2024 annual result was $10096.0, down 61.74% from the prior year.
• Other Non-Current Liabilities eased to $35.0 in Q3 2025 per ENSCW's latest filing, from $1033.0 in the prior quarter.
• Over five years, Other Non-Current Liabilities peaked at $8.3 million in Q1 2021 and troughed at $35.0 in Q3 2025.
• A 5-year average of $1.3 million and a median of $335571.5 in 2022 frame the typical range for Other Non-Current Liabilities.
• On a YoY basis, Other Non-Current Liabilities climbed as much as 47.82% in 2022 and fell as far as 91.5% in 2022.
• A 5-year view of Other Non-Current Liabilities shows it stood at $3.7 million in 2021, then slumped by 91.5% to $310346.0 in 2022, then sank by 91.5% to $26388.0 in 2023, then sank by 61.74% to $10096.0 in 2024, then plunged by 99.65% to $35.0 in 2025.
• Business Quant data shows ENSCW's Other Non-Current Liabilities at $35.0 in Q3 2025, $1033.0 in Q2 2025, and $130180.0 in Q1 2025.